Patent · US Expired

Pyrimidine derivatives for enhancing antitumor activity

US5491234A · kind A · utility

5Cited by
4References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 1993
Grant dateFeb 13, 1996
Priority date
Expiry dateOct 14, 2013

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

2,4-diaminopyrimidine derivatives as potentiators of chemotherapeutic agents in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.